Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 127,422 shares at $26.08 ($3.4M) on 2021-09-07, disclosed to the SEC on 2021-09-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.74 | 29,822 | $797K | 23.6% |
| 2 | $26.74 | 29,822 | $797K | 23.6% |
| 3 | $27.29 | 1,378 | $38K | 1.1% |
| 4 | $26.08 | 28,287 | $738K | 21.9% |
| 5 | $26.08 | 28,287 | $738K | 21.9% |
| 6 | $27.12 | 4,913 |
| $133K |
| 3.9% |
| 7 | $27.12 | 4,913 | $133K | 3.9% |
| Total | $26.48 avg | 127,422 | $3.4M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-16 | $7.1M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |
| MYOV | BUY | 2021-08-24 | $4.4M | — | Filing → |